Showing results (1071-1080 of 1,137) with videos related to
Sort By:
Pageof 114
Oncoimmunology|November 18, 2016
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8<sup>+</sup> and CD4<sup>+</sup> T-cell responses with multiple specificities including a novel DR7-restricted epitopeP Baumgaertner, C Costa Nunes, A Cachot, et al.Immunological Reviews|November 26, 2002
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanomaPedro Romero, Danila Valmori, Mikael J Pittet, et al.Cell Reports|July 4, 2019
Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human LifespanJesse J Salk, Kaitlyn Loubet-Senear, Elisabeth Maritschnegg, et al.The New England Journal of Medicine|June 3, 2024
Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal HyperplasiaKyriakie Sarafoglou, Mimi S Kim, Maya Lodish, et al.Science Translational Medicine|October 15, 2020
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanomaAnusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi, et al.Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Long-read sequencing resolves the clinically relevant <i>CYP21A2</i> locus, supporting a new clinical test for Congenital Adrenal HyperplasiaJean Monlong, Xiao Chen, Hayk Barseghyan, et al.Nature|December 5, 2022
Dendritic cells direct circadian anti-tumour immune responsesChen Wang, Coline Barnoud, Mara Cenerenti, et al.Contemporary Clinical Trials|January 19, 2026
Expanding access to cancer genetic care for cancer survivors: Rationale and design for a randomized controlled trial of a chatbot-based genetic education and testingJinghua An, Maisha Huq, Erin Speiser, et al.Cells|March 1, 2019
Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open QuestionsMarina Bagnoli, Ting Yan Shi, Charlie Gourley, et al.Gynecologic Oncology|September 2, 2018
The genetic landscape of 87 ovarian germ cell tumorsEls Van Nieuwenhuysen, Pieter Busschaert, Patrick Neven, et al.Pageof 114